Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CdLS NeuN-negative RNAseq

ABSTRACT: CdLS NeuN-negative RNAseq

PROVIDER: PRJNA631220 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11734458_1.fastq.gz	Fastqsanger.gz
	SRR11734458_2.fastq.gz	Fastqsanger.gz
	SRR11734459_1.fastq.gz	Fastqsanger.gz
	SRR11734459_2.fastq.gz	Fastqsanger.gz
	SRR11734460_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 54

Similar Datasets

CdLS NeuN-negative RNAseq

Project description:RNA-seq of NeuN-negative nuclei from CdLS patients and healthy age-matched controls

2021-02-28 | GSE150117 | GEO

CdLS NeuN-positive RNAseq

Project description:CdLS NeuN-positive RNAseq

| PRJNA631223 | ENA

CdLS NeuN-positive RNAseq

Project description:RNA-seq of NeuN-positive nuclei from CdLS patients and healthy age-matched controls

2021-02-28 | GSE150118 | GEO

CdLS NeuN-positive ATACseq

Project description:ATAC-seq of NeuN-positive nuclei from CdLS patients and healthy age-matched controls

2021-02-28 | GSE150079 | GEO

CdLS NeuN-positive ATACseq

Project description:CdLS NeuN-positive ATACseq

| PRJNA631041 | ENA

ATAC-Seq for control and Huntington's disease mouse models for neun+ and neun- cells

Project description:Data collected from HD and control mouse models for multiple brain regions (striatum vs. cortex), time points (8 weeks vs. 12 weeks), and cell types (NeuN+ vs. Neun-)

2022-07-14 | GSE180236 | GEO

Human cortical nuclei RNAseq

Project description:RNA-seq of NeuN-negative and NeuN-positive nuclei from healthy controls

2021-02-28 | GSE150121 | GEO

ATAC-Seq for control and Huntington's disease mouse models for neun+ and neun- cells

Project description:ATAC-Seq for control and Huntington's disease mouse models for neun+ and neun- cells

| PRJNA747164 | ENA

Defective Cohesin in CdLS Mediates Gene Expression with Characteristics of Transcription Factor and Insulator Activity

Project description:The Cohesin apparatus has a canonical role in sister chromatid cohesion. Heterozygous mutations in Nipped B-like (NIPBL), SMC1A, and SMC3 have been found in 60% of probands with Cornelia de Lange Syndrome (CdLS), a dominant multi-system genetic disorder with variable expression. We have performed a genome-wide transcription assessment as well as cohesin binding analysis using human lymphoblastoid cell lines (LCLs) from probands with CdLS and controls. Here, we report a unique profile of genes dysregulated in CdLS that correlates with different clinical presentations. Genome-wide analysis of cohesin binding demonstrates a preference for intergenic regions suggesting a cis-regulatory function mimicking that of an insulator. However, the binding sites are enriched within the promoter regions of the dysregulated genes and are significantly decreased in CdLS probands, indicating an alternative role of cohesin as a classic transcription factor. Cohesin also co-localizes with CTCF at the boundary elements affecting neighboring gene expression in CdLS probands. We propose that the CdLS phenotype is the result of dysregulated gene expression rather than defective sister chromatid cohesion. Phenotype specific expression profiles are also described. Keywords: Disease state analysis, Genetic modification

2009-05-28 | GSE12408 | GEO

Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas based technology

Project description:Cornelia de Lange syndrome (CdLS) is an autosomal dominant disease mainly caused by mutations in the Nipped-B-like protein (NIPBL) gene resulting in the alteration of the cohesin pathway. Here, we generated human induced pluripotent stem cells (hiPSCs) from a CdLS patient carrying a mutation in the NIPBL gene, c.5483G>A, and tested CRISPR-Cas based approaches to repair the genetic defect. We applied an efficient and precise method of gene correction through CRISPR-Cas induced homology directed repair (HDR), which allowed the generation of hiPSC clones with regular karyotype and preserved stemness. The efficient and precise gene replacement strategy developed in this study can be extended to the modification of other genomic loci in hiPSCs. Isogenic wild-type and mutated hiPSCs produced with the CRISPR-Cas technology are fundamental CdLS cellular models to study the disease molecular determinants and identifying therapeutic targets.

2023-03-17 | E-MTAB-11604 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data